Do high numbers of salivary gland-infiltrating B cells predict better or worse outcomes after rituximab in patients with primary Sjögren's syndrome?

Ann Rheum Dis. 2016 Jun;75(6):e33. doi: 10.1136/annrheumdis-2016-209300. Epub 2016 Feb 19.
No abstract available

Keywords: B cells; DMARDs (biologic); Sjøgren's Syndrome.

Publication types

  • Letter
  • Comment

MeSH terms

  • B-Lymphocytes
  • Humans
  • Rituximab*
  • Salivary Glands
  • Sjogren's Syndrome*

Substances

  • Rituximab